← Back to Patent Explorer
US4962188A Expired / Lapsed US ⏱️ 0.0 years remaining

Recombinant ricin toxin A chain conjugates

Assignee: Novartis Vaccines and Diagnostics Inc
•
Filing: 1986-09-30
•
Granted: 1990-10-09
•
Expires: 2006-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Conjugates comprising recombinant ricin toxin A chain and a binding moiety which may be an antigen binding portion selected from the group consisting of Fab, Fab' and F(ab')2 fragments of monoclonal or polyclonal antibodies, hormones, lectins or other compounds that are recognized by cell receptors, are described and claimed.

Inventors

  • 👤 Arthur E. Frankel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:38
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; C07K16/30; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/68; A61K47/6835; A61K47/6851; A61K47/6869; A61K38/00; Y; Y10; Y10S; Y10S424/00; Y10S424/804; Y10S424/806; Y10S424/807; Y10S530/00; Y10S530/808; Y10S530/861; Y10S530/863; Y10S530/864

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 78 words
A conjugate comprising unglycosylated recombinant ricin toxin A chain and a murine monoclonal antibody, said conjugate being maintained in an effective cytotoxic amount in the circulation of a host animal for substantially longer times than similar conjugates made of native ricin A chain, wherein said monoclonal antibodies are selected from the gorup consisting of 2G3, 9C6, 33F8, 44B2, 44F4, 120H7, 200F9, 204F4, 219F3, -245E7, 260F9, 266B2, 280D11, 317G5, 369F10, 388D4, 421E8, 451C3, 454A12, 454C11, 650E2, -788G6, and 871E3.
Claim 2
Dependent Claim 78 words
A conjugate comprising unglycosylated recombinant ricin toxin A chain and a murine monoclonal antibody, said conjugate being maintained in an effective cytotoxic amount in the circulation of a host animal for substantially longer times than similar conjugates made of native ricin A chain, wherein said monoclonal antibodies are selected from the gorup consisting of 2G3, 9C6, 33F8, 44B2, 44F4, 120H7, 200F9, 204F4, 219F3, -245E7, 260F9, 266B2, 280D11, 317G5, 369F10, 388D4, 421E8, 451C3, 454A12, 454C11, 650E2, -788G6, and 871E3.
Claim 3
Dependent Claim 35 words
The conjugate as described in claim 1, wherein said conjugates have the property of being cleared about nine times slower from the circulation of a host animal than conjugates made of native ricin A chain.

References Cited (Backward Citations)

US4340535A Cited
US4359457A Cited
US4434156A Cited
US4522918A Cited
US4675382A Cited
US4504586A Cited
EP0145111A1 Cited
US4545985A Cited
US4806494A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-10-08 1994-04-09 1994-10-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-10-08 1998-04-09 1998-10-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-10-08 2002-04-09 2002-10-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag